tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

AEON Stock Latest News

AEON Biopharma’s $20M Offering for ABP-450 Development
Company AnnouncementsAEON Biopharma’s $20M Offering for ABP-450 Development
12d ago
8K
AEON
Aeon Biopharma prices 40M units at 50c in underwritten public offering
PremiumThe Fly
Aeon Biopharma prices 40M units at 50c in underwritten public offering
12d ago
AEON
AEON Biopharma Releases New Investor Presentation
PremiumCompany Announcements
AEON Biopharma Releases New Investor Presentation
3M ago
8K
AEON
Aeon Biopharma announces outcome from FDA biosimilar advisory meeting
PremiumThe Fly
Aeon Biopharma announces outcome from FDA biosimilar advisory meeting
4M ago
AEON
Aeon Biopharma files $200M mixed securities shelf
PremiumThe Fly
Aeon Biopharma files $200M mixed securities shelf
5M ago
AEON
Aeon Biopharma price target lowered to $5 from $6 at H.C. Wainwright
PremiumThe FlyAeon Biopharma price target lowered to $5 from $6 at H.C. Wainwright
5M ago
AEON
AEON Biopharma Releases New Corporate Presentation
Premium
Company Announcements
AEON Biopharma Releases New Corporate Presentation
5M ago
8K
AEON
3 Penny Stocks to Watch Now, 7/18/24
Premium
Market News
3 Penny Stocks to Watch Now, 7/18/24
6M ago
AEON
NAAS
Aeon announces reprioritization to pursue biosimilar pathway for ABP-450
PremiumThe Fly
Aeon announces reprioritization to pursue biosimilar pathway for ABP-450
6M ago
AEON
Aeon Biopharma discontinues Phase 2 study of ABP-450 in chronic migraine
PremiumThe Fly
Aeon Biopharma discontinues Phase 2 study of ABP-450 in chronic migraine
8M ago
AEON
Aeon announces strategic resource reprioritization, cuts workforce by 55%
PremiumThe Fly
Aeon announces strategic resource reprioritization, cuts workforce by 55%
8M ago
AEON
AEON Biopharma Halts Migraine Study and Evaluates Strategy
PremiumCompany Announcements
AEON Biopharma Halts Migraine Study and Evaluates Strategy
8M ago
8K
AEON
Aeon Biopharma price target lowered to $6 from $18 at H.C. Wainwright
PremiumThe FlyAeon Biopharma price target lowered to $6 from $18 at H.C. Wainwright
8M ago
AEON
Aeon Biopharma provides update on development pipeline
Premium
The Fly
Aeon Biopharma provides update on development pipeline
8M ago
AEON
Aeon’s results from Phase 2 trial of ABP-450 didn’t meet primary endpoint
Premium
The Fly
Aeon’s results from Phase 2 trial of ABP-450 didn’t meet primary endpoint
9M ago
AEON
AEON Biopharma Phase 2 Migraine Treatment Trial Results
PremiumCompany Announcements
AEON Biopharma Phase 2 Migraine Treatment Trial Results
9M ago
8K
AEON
AEON Biopharma Bolsters Finance and Board with Daewoong Deal
PremiumCompany Announcements
AEON Biopharma Bolsters Finance and Board with Daewoong Deal
9M ago
8K
AEON
AEON Biopharma Announces Warrant Exercise Deadline and Terms
PremiumCompany Announcements
AEON Biopharma Announces Warrant Exercise Deadline and Terms
9M ago
8K
AEON
AEON Biopharma Secures Strategic Financing for Clinical Development
PremiumCompany Announcements
AEON Biopharma Secures Strategic Financing for Clinical Development
10M ago
8K
AEON
Aeon: EOP2 meeting with FDA productive, defined primary endpoint for Phase 3
PremiumThe FlyAeon: EOP2 meeting with FDA productive, defined primary endpoint for Phase 3
10M ago
AEON
Aeon Biopharma presents new data from ABP-450 trial
Premium
The Fly
Aeon Biopharma presents new data from ABP-450 trial
1y ago
AEON
Aeon Biopharma completes enrollment in Phase 2 study of ABP-450
Premium
The Fly
Aeon Biopharma completes enrollment in Phase 2 study of ABP-450
1y ago
AEON

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >